AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 51 filers reported holding AEVI GENOMIC MEDICINE INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $131,000 | – | 98,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $154,000 | 0.09% |
| Baker Brothers Advisors | 4,055,142 | $4,866,000 | 0.04% |
| Verity Asset Management, Inc. | 14,500 | $28,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $6,600,000 | 0.02% |
| HYMAN CHARLES D | 15,143 | $18,000 | 0.00% |
| Cable Hill Partners, LLC | 4,000 | $5,000 | 0.00% |
| Wealthcare Advisory Partners LLC | 5,000 | $6,000 | 0.00% |
| A.R.T. Advisors, LLC | 41,879 | $50,000 | 0.00% |
| Legacy Advisors, LLC | 2,450 | $2,000 | 0.00% |
| OneDigital Investment Advisors LLC | 7,800 | $9,000 | 0.00% |